China Resources Double-crane Pharmaceutical Co., Ltd. Class ASSE: 600062

"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtaining the Drug Registration Certificate for Lomustine Capsules

Sep 2, 2026 · Issued by China Resources Double-crane Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Obtaining the Drug Registration Certificate for Lomustine Capsules

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from China Resources Double-crane Pharmaceutical Co., Ltd. Class A

"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on the Obtaining of the Drug Registration Certificate for Oxcarbazepine Tablets by the Controlled Subsidiary, China Resources Double-Crane Xiangzhong Pharmaceutical (Hunan) Co., Ltd.Sep 1
"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Progress in Major Asset RestructuringAug 29
"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on the Profit Distribution Plan for the First Half of 2026Aug 22
"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on the Obtaining of the Drug Registration Certificate for Lidocaine Hydrochloride GelAug 19

All China Resources Double-crane Pharmaceutical Co., Ltd. Class A news releases